Brochures

Leader Biomedical’s Joint Care Intervention portfolio offers a targeted solution for deferring osteoarthritis with Hyalosyn™ Gel. The Hyaluronic Acid (HA) injections supplement the natural human…

Leader Biomedical’s Joint Care Reconstruction portfolio combines proven and time-tested designs with the latest in bearing and coating technologies and include systems for both total…

Leader Biomedical’s Spine Intervention portfolio offers targeted solutions for deferring osteoarthritis, spinal fusion, and adhesion control and prevention.

Leader Biomedical’s Dental Reconstruction Portfolio offers targeted therapeutic solutions for reconstruction addressing maxillofacial bone defects with eTiss® allografts and demineralised bone matrix (DBM)

Leader Biomedical’s Sports Medicine Intervention portfolio offer a targeted solution for deferring osteoarthritis with Hyalosyn™ Gel Hyaluronic Acid (HA) injections. These injections supplement the natural…

Leader Biomedical’s Sports Medicine Reconstruction portfolio offers a targeted therapeutic solution for Anterior Cruciate Ligament (ACL) reconstruction addressing ligament injury with the X-Grip® system that…

eCOO® Technology is Leader Biomedical’s proprietary platform of cleaning, sterilising, and impregnating human and animal derived tissues, that utilises the unique characteristics of supercritical carbon…

Perfecting bone regeneration with allografts and synthetic bone grafts. Leader Biomedical’s Orthobiologics portfolio offers both high-quality allografts and synthetic bone grafts, as these do not require…

Produced at our accredited facilities in Europe, Leader Biomedical’s line of C-ment® and Genta C-ment® bone cements have been marketed in Europe and across the…

Adcon® Gel provides a physical barrier to inter-tissue adhesions and inhibits fibroblast migration and ingrowth. This results in improved patient rehabilitation, reduced recurrent pain, and…